Author Topic: Here We Go: Monkeypox Hits USA (Read 5855 times)

SeanJohnson · « **on:** May 19, 2022, 01:10:23 PM »

US Confirms Monkeypox Virus In Massachusetts After UK, Spain, Portugal Cases In Men

BY TYLER DURDEN

INVALID DATE

Authored by Caden Pearson via The Epoch Times(emphasis ours),
A single case of the rare but serious monkeypox virus has been confirmed in Massachusetts in a man. Recent cases in the United Kingdom, Spain, and Portugal have been linked to men who have sex with other men.

A general view of the Centers for Disease Control headquarters in Atlanta, Ga., on April 23, 2020. (Tami Chappell/AFP via Getty Images)

The U.S. Centers for Disease Control and Prevention (CDC) confirmed the U.S. case on Wednesday, after initial testing completed late Tuesday at the State Public Health Laboratory in Jamaica Plain.
The man poses no risk to the public and is in hospital in good condition, the Massachusetts Department of Public Health (DPH) said in its release.
Contact tracing efforts are underway between Massachusetts DPH, the CDC, relevant local health officials, and the man’s health care providers.
The United Kingdom has confirmed nine cases of monkeypox since early May. The first of these cases had recently traveled to Nigeria. None of the other cases reported recent travel.
Five cases were also confirmed in Portugal on Wednesday in young men, with 15 cases under investigation.
Health authorities in Spain said late on Wednesday that they were also assessing 23 possible cases of monkeypox, mostly in men who have sex with men.
The Epoch Times contacted Massachusetts DPH for further relevant information regarding the U.S. case.

Monkeypox symptoms typically begin with flu-like illness and swelling of the lymph nodes. It progresses to a rash on the face and body. Most infections last two to four weeks.
The virus does not easily spread between people, according to Massachusetts DPH.
Transmission can occur through contact with body fluids, monkeypox sores, items such as clothing or bedding contaminated with fluids or sores, or through respiratory droplets following prolonged face-to-face contact.
Massachusetts DPH is advising clinicians to consider a diagnosis of monkeypox in people who present with an otherwise unexplained rash, have had recent overseas travel in the last 30 days to places with confirmed or suspected cases, have had contact with confirmed or suspected cases, or is a man who reports sɛҳuąƖ contact with other men.
The advice is based on the findings of the U.S. case and recent UK cases, and is in line with recommendations from UK health officials and U.S. federal health officials.
Health care providers are being told that monkeypox illness could be clinically confused with a sɛҳuąƖly transmitted infection syphilis or herpes, or with varicella zoster virus.
Patients may present with early flu-like symptoms and progress to lesions that may begin on one site on the body and spread to other parts.

It is very rare for the disease to occur in the United States, with most cases linked to international travel or importing animals from places where the disease is common, such as central and west Africa, according to the CDC.
In central and west Africa, people can be exposed through bites or scratches from rodents and small mammals, preparing wild game, or having contact with an infected animal or possible animal products.
A Texas man who traveled to Nigeria was confirmed to have monkeypox in July 2021.
[ZH: For a deeper dive on monkeypox John Campbell gives an excellent rundown]

DigitalLogos · « **Reply #1 on:** May 19, 2022, 01:12:32 PM »

Quote

23 possible cases of monkeypox, mostly in men who have sex with men.

Sounds like God's vengeance more than anything to me.

jvk · « **Reply #2 on:** May 20, 2022, 05:39:21 AM »

Gosh, that makes me want to throw up. Can't someone just whack something off of them?! (Remember the Bobbit's?) A little venting here. I am so sick, sick sick SICK of transgender this, ɧoɱosɛҳųαƖ that, birth "person", preferred pronouns of "them, they, their"...Gaa. Perverts.

SeanJohnson · « **Reply #3 on:** May 20, 2022, 05:42:37 AM »

Why Wiping Out Smallpox Has Stoked Risk of Monkeypox

Monkeypox virions, left, obtained from a sample of human skin.

Source: Centers for Disease Control and Prevention/AP Photos

By
Jason Gale
+Follow
May 19, 2022, 11:19 PM CDTUpdated onMay 20, 2022, 2:54 AM CDT
From

https://www.bloomberg.com/news/articles/2022-05-20/why-wiping-out-smallpox-has-stoked-risk-of-monkeypox-quicktake

The global eradication of smallpox more than 40 years ago was one of the greatest achievements in public-health history, vanquishing a cause of death, blindness and disfigurement that had plagued humanity for at least 3,000 years. But, on the downside, it led to the end of a global vaccination program that provided protection against other pox viruses. That includes monkeypox, which has been spilling over from its animal hosts to infect humans in Africa with increasing frequency since the 1970s. More recently, monkeypox has sparked outbreaks in Europe and North America, demonstrating again how readily an infectious agent that emerges in one country can become an international concern.
1. What’s monkeypox?
“Monkeypox” is a misnomer resulting from the fact it was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. While monkeys are susceptible to it, just like humans are, they aren’t the source. The virus belongs to the Orthopoxvirus genus, which includes the variola virus, the cause of smallpox; the vaccinia virus, which is used in the smallpox vaccine; and cowpox virus. Monkeypox is less contagious than smallpox and the symptoms are milder. About 30% of smallpox patients died, while the fatality rate for monkeypox in recent times is around 3% to 6%, according to the աօʀʟd ɦɛaʟtɦ օʀɢaռiʐatɨօռ.
2. What does monkeypox do?
After an incubation period of usually one to two weeks, the disease starts with fever, muscle aches, fatigue and other flu-like symptoms. Unlike smallpox, monkeypox causes swelling of the lymph nodes. Within a few days of fever onset, patients develop a rash, often beginning on the face then spreading to other parts of the body. The lesions grow into fluid-containing pustules that form a scab. If a lesion forms on the eye it can cause blindness. The illness typically lasts two to four weeks, according to the WHO. The person is infectious from the onset of symptoms until the scabs fall off. Some patients have genital lesions and the rash may be hard to distinguish from syphilis, herpes simplex virus infection, shingles and other more common infections, according to the US Centers for Disease Control and Prevention. Mortality is higher among children and young adults, and people whose immune system is compromised are especially at risk of severe disease.
3. Where does it come from?
The reservoir host or main carrier of monkeypox disease hasn’t yet been identified, although rodents are suspected to play a part in transmission. It was first diagnosed in humans in 1970 in the Democratic Republic of the Congo in a 9-year-old boy. Since then most cases in humans have occurred in rain forest areas of Central and Western Africa. In 2003, the first outbreak outside of Africa was in the US and was linked to animals imported from Ghana to Texas, which then infected pet prairie dogs. Dozens of cases were recorded in that outbreak.
4. How is it transmitted?
Monkeypox doesn’t spread easily between people. Contact with the virus from an animal, human or contaminated objects is the main pathway. The virus enters the body through broken skin, the respiratory tract or the mucous membranes in the eyes, nose or mouth. Human-to-human transmission is thought to occur mainly through large respiratory droplets, but can also following contact with body fluids or lesion material, or indirectly through contact with contaminated clothing or linens. It may also be transmitted during sex. Common household disinfectants can kill the monkeypox virus.
5. How often does it occur?

Monkeypox is endemic in many parts of West and Central Africa. Outbreaks outside the continent occur infrequently -- at least eight known exported cases since 2017 -- usually involving international travelers. They don’t typically cause onward transmission. In May 2022, however, more than two dozen cases were confirmed in the UK, Portugal, Spain, Italy, Sweden, Belgium, Canada and the US. Australia confirmed two cases on May 20 in men who had recently flown back from Europe.
6. What’s unusual about this outbreak?

The day's biggest stories

Get caught up with the Evening Briefing.

Email

By submitting my information, I agree to the Privacy Policy and Terms of Service and to receive offers and promotions from Bloomberg.

It’s led to multiple chains of transmission in clusters in multiple countries that don’t normally report monkeypox. The cases don’t involve recent travel. Instead, community spread is suspected among individuals who self-identify as men who have sex with men -- suggesting transmission through close sɛҳuąƖ and personal contact. The cases are thought to have been caused by a West African “clade,” or strain, which has a case-fatality rate of 1% to 3.6%. (That compares with 10% for a second strain called Congo Basin, which appears on the US government’s bioterrorism agent list as having the potential to pose a severe threat.)
7. Is monkeypox a pandemic threat?
The emergence cases involving human-to-human transmission has raised concern that the virus may undergo genetic changes and become more adept at spreading from person to person. Still, even the Democratic Republic of the Congo, where thousands of infections occur annually, that has yet to occur.
8. How is it treated and prevented?
The illness is usually mild and most patients will recover within a few weeks; treatment is mainly aimed at relieving symptoms. For the purposes of controlling a monkeypox outbreak, the CDC says smallpox vaccine, antivirals, and vaccinia immune globulin can be used. Vaccination against smallpox can be used for both pre- and post-exposure and is as much as 85% effective in preventing monkeypox, according to the UK Health Security Agency. It lists cidofovir and tecovirimat as antiviral drugs that can be used to control monkeypox outbreaks. Tecovirimat was approved by the European Medical Association for monkeypox in 2022 based on data in animal and human studies, but isn’t yet widely available, according to the WHO. Newer vaccines have been developed, of which one has been approved for prevention of monkeypox. The main way to prevent infection is by isolating patients suspected of having monkeypox in a negative pressure room, and ensuring health staff wear appropriate personal protective equipment.
9. Is there a test for monkeypox?
Yes, monkeypox is diagnosed based on the detection using real-time polymerase chain reaction (PCR) tests of viral DNA in specimens collected from the scabs or swabs of a patient’s lesions. In the US, these are available at state health departments and the CDC.

SeanJohnson · « **Reply #4 on:** May 20, 2022, 05:46:06 AM »

Here We Go Again: Biden Administration Buys Millions of Doses of Monkeypox Vaccine After Case is Confirmed in Massachusetts – Health Officials Currently Investigating Second Potential Case in NYC
By Julian Conradson
Published May 19, 2022 at 8:55pm
Comment

With midterms fast approaching, Democrat approval ratings cratering out of control, the hysteria surrounding Covid-19 rapidly waning, it seemed like it was only a matter of time before another crisis developed that would help the Left reinstitute the tyrannical control mechanisms they used throughout the China-virus pandemic.

Well,now we have monkeypox – a viral infection that is traditionally mild and rare in humans – popping up all across the Western countries. Oddly enough, the virus is seemingly spreading from person to person like never before, leaving many people, including those in the scientific community, scratching their heads and asking themselves: ‘what is going on?’

Now, we are obviously a long way off from what we experienced with the last pandemic, but, either way – whether the origins of this more transmissible monkeypox virus are natural, or something else (like Covid-19, Wuhan, etc.) – the timing of this new outbreak is curious – to say the least.

With a recent surge of nearly 40 cases in Europe, the first positive case being confirmed in the US on Wednesday in Massachusetts, and a second potential casenow being investigated by health officials in New York City, the Biden administration is wasting no time in ‘preparing’ for the next public health emergency.

On Thursday, the Federal government ordered 13 million monkeypox vaccinesfrom the European biotechnology company Bavarian-Nordic, according to Newsweek. In all, a total of $119 million was spent on the ‘Jynneos’ vaccines, which works out to about $9.15 per dose.

From Newsweek:

Quote

“The order amounts to a $119 million order for Jynneos vaccines, which are used for the prevention of both smallpox and monkeypox. It was announced by biotechnology company Bavarian Nordic, which makes the vaccine, on Wednesday.
The order will convert bulk vaccines, which have already been made and invoiced under previous contracts with the U.S. government, into freeze-dried versions which have an improved shelf-life.”

A press release announcing the sale by Bavarian-Nordic clarified some of the specifics of the purchase agreement with the U.S. Biomedical Advanced Research and Development Authority (BARDA), which is part of the U.S. Department of Health and Human Services. According to their announcement, the agency had “exercised the first options under the contract to supply a freeze-dried version of JYNNEOS^® smallpox vaccine.”
The first doses of this version of the monkeypox vaccine are expected to be delivered and invoiced in 2023 and 2024.

Advertisement - story continues below

As for the severity of the disease, monkeypox is traditionally mild and will typically resolve within 2-4 weeks, although more severe cases do occasionally develop, according to the New Jersey Department of Agriculture. In less-developed, non-western countries, the disease’s mortality rate ranges anywhere from 1-15%; however, during a 2004 outbreak in the US, just 2 out of 74 people fell severely ill, and all of them made full recoveries.
From NJ DOA:

Quote

“Estimates of the case-fatality rate for monkeypox in Africa vary from 1% to 15%, with the highest risk of death in young children. In one study of 300 patients in the Democratic Republic of Congo, the overall mortality rate was 10% and the mortality rate in unvaccinated children was 15-20%. Respiratory complications occurred in 12% of patients in this study.
During an outbreak of monkeypox in the U.S. in 2003, most cases appeared to be the result of contact with sick prairie dogs. Two of 79 patients became severely ill, one with encephalitis. No deaths occurred to July 1, 2003.”

The main concern with this latest outbreak is that the cases seem to be spreading through human-to-human transmission at an alarming rate. Traditionally, the virus has been zoonotic and normally has a hard time making the jump from animals to humans, so the new developments are worth keeping an eye on – especially with what Gates, Fauci, and the rest of the so-called ‘public health experts’ have been up to for the past few years.

Clearly, they are prepping the needles for more vaccinations, but what else is in store this time around?

CathInfo.com

Author Topic: Here We Go: Monkeypox Hits USA (Read 5855 times)

SeanJohnson

Here We Go: Monkeypox Hits USA

DigitalLogos

Re: Here We Go: Monkeypox Hits USA

jvk

Re: Here We Go: Monkeypox Hits USA

SeanJohnson

Re: Here We Go: Monkeypox Hits USA

SeanJohnson

Re: Here We Go: Monkeypox Hits USA